Size
~2–50 amino acids (∼0.2–5 kDa)
Structure
Linear or cyclic; natural or synthetic
Stability
Tunable via cyclization and non-natural residues
Production
Solid-phase synthesis or recombinant
Key Features
Cyclization and incorporation of D-amino acids or peptidomimetics can dramatically improve stability and potency.
- High specificity with small footprint
- Rapid synthesis and optimization cycles
- Amenable to conjugation (labels, payloads, PEG)
Unmodified linear peptides often have short serum half-life due to proteolysis and renal clearance.
Applications
Therapeutic Modulators
Therapeutic Modulators
Receptor agonists/antagonists, enzyme inhibitors, and signaling modulators.
Targeting Moieties
Targeting Moieties
Direct payloads to tissues or cells; imaging probes and ADC-like constructs.
Diagnostics
Diagnostics
Short, robust binders for assays and biosensors.
Peptide libraries enable high-throughput discovery (e.g., phage display, mRNA display) of potent binders with tailored properties.